Effervescent powders for inhalation

Details Effervescent powders for inhalation Effervescent powders for inhalation

2011-05-24

2011-05-24

Acevedo, James H Alstrum (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S046000, C514S034000, C514S312000, C514S777000, C514S784000, C977S773000

Reexamination Certificate

active

07947308

ABSTRACT:
Effervescent powders comprising inhalable particles are disclosed, as are methods for preparing these powders. The inhalable carrier particles comprise an inorganic or organic carbonate, and an acid, and exhibit effervescence when exposed to water or humid air. The particles have a mass median aerodynamic diameter suitable for nasal, bronchial, or pulmonary administration. The inhalable particles may be used as carriers for active agents. The inhalable particles may also be used to enhance permeability of mucosal and surface barriers on an inner surface of the nose, mouth, airway, and/or lungs of a patient, as well as to loosen, thin, cleanse, and remove mucus and extrinsic surface materials from an inner surface of the nose, mouth, airway, and/or lungs of a patient in need thereof.

REFERENCES:
patent: 5192528 (1993-03-01), Radhakrishnan et al.
patent: 6683043 (2004-01-01), Dovey et al.
patent: 2002/0020412 (2002-02-01), Gilbert et al.
patent: 2004/0107963 (2004-06-01), Finlay et al.
patent: 2005/0124663 (2005-06-01), Gatlin et al.
patent: 2006/0112958 (2006-06-01), Fisher et al.
patent: 2009/0181100 (2009-07-01), Bosch et al.
Hershey et al. “Inhalation Chemotherapy for Macroscopic Primary or Metastatic Lung Tumors: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model,” Clinical Cancer Research, 1999, vol. 5, pp. 2653-2639.
Merck Index, 10th edition, entry 3435, Merck & Co., Inc.: Rahway, NJ, 1983, pp. 499.
Abraxane [prescribing information]. Schaumburg, III: Abraxis Oncology, a Division of American Pharmaceutical Partners, Inc; Jan. 2005.
Bosquillon, C. et al., “Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerolization performance,”Journal of Controlled Release, 2001, 70, 329-339.
Bosquillon, C. et al., “Pulmonary delivery of growth hormone using dry powders and visulization of its local fate in rats,”Journal of Controlled Release, 2004, 96, 233-244.
Codrons, V. et al., “Systemic delivery of parathyroid hormone (1-34) using inhalation dry powder in rats,”Journal of Pharmaceutical Sciences, 2003, 92(5), 938-950.
Corrigan, D. O. et al., “The effect of spray drying solutions of polyethylene glycol (PEG) and lactose/PEG on their physicochemical properties,”International J. of Pharmaceutics, 2002, 235, 193-205.
Dailey, L. A., et al., “Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features,”Journal of Controlled Release, 2003, 86, 131-144.
Davies, N. M. et al., “A novel method for assessing dissolution of aerosol inhaler products,”International Journal of Pharmaceutics, 2003, 255, 175-87.
Edwards, D. A. et al., “Recent advances in pulmonary drug delivery using large, porous inhaled particles,”J Appl Physiol, 1998, 85, 379-385.
Eichman, J. D. et al., “Mechanistic studies on effervescent—induced permeability enhancement,”Pharmaceutical Research, 1998, 15(6), 925-930.
El-Shaboury, M. H. et al., “Effect of effervescent salt on the dissolution and bioavailability of drugs from capsules filled on a dosator-type capsule-filling machine,”Pharmazeutische Industrie, 1993, 55(2), 176-179.
Elversson, J. et al., “Droplet and Particle Size Relationship and Shell Thickness of Inhalable Lactose Particles during Spray Drying,”Journal of Pharmaceutical Sciences, 2002, 92(4), 900-910.
Garcia-Contreras, L. et al., “Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy,”Advanced Drug Delivery Reviews, 2002, 54, 1491-1504.
Gilani, K. et al., “Aerolization of beclomethasone diprionate using spray dried lactose/polyethylene glycol carriers,”European J. of Pharmaceutics and Biopharmaceutics, 2004, 58, 596-606.
Gliński, J. et al., “Surface properties of aqueous solutions of L-leucine,”Biophysical Chemistry, 2000, 84, 99-103.
Grenha, S. B. et al., “Microencapsulated chitosan nanoparticles for lung protein delivery,”European Journal of Pharmaceutical Sciences, 2005, 25, 427-437.
Hardy, J. G. et al., “Sustained Release Drug Delivery to the lungs,”Clin Pharmacokinet, 2000, 39, 1-4.
Karhu, M. et al., “Pulmonary deposition of lactose carrier used in inhalation powders,”International J. of Pharmaceutics, 2000, 196, 95-103.
King, M. et al., “Clearance of mucus by simulated cough,”J. Appl. Physiol., 1985, 58(6), 1776-1782.
Kreuter, J., “Nanoparticle-based dmg delivery systems,”Journal of Controlled Release, 1991, 16, 169-176.
Labiris, N. R. et al., “Pulmonary Drug Delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications,”Journal Clin Pharmacol., 2003, 56, 588-599.
Lucas, P. et al., “Enhancement of small particles size dry powder aerosol formulations using an ultra low-density additive,”Pharmaceutical Research, 1999, 16(10), 1643-1647.
Oberdörster, G. et al., “An Emerging Discipline Evolving from Studies of Ultrafine Particles,”Environmental Health Perspectives, 2005, 113(7), 823-839.
Pandey, R. et al., “Antitubercular inhaled therapy: opportunities, progress and challenges,”The Journal of Antimicrobial Chemotherapy, 2005, 55(4), 430-435.
Petersen, F. J. et al., “Design and Atomization Properties for an Inside-Out Type Effervescent Atomizer,”Drug Development and Industrial Pharmacy, 2004, 30(3), 319-326.
Rabbani, N. R. et al., “The influence of formulation components on the aerolization properties of spray dried powders,”J of Controlled Release, 2005, 110, 130-140.
Rao, R. D. et al., “Aerosol Therapy for Malignancy Involving the Lungs,”Current Cancer Drug Targets, 2003, 3(4), 239-250.
Rotthauser, B. et al., “Optimization of an effervescent tablet formulation containing spray dried L-Leucine and polyethylene glycol 6000 as lubrificants using a central composite design,”European Journal of Pharmaceutics and Biopharmaceutics, 1998, 46, 85-94.
Rygnestad, T. et al., “Absorption of effervescent paracetamol tablets relative to ordinary paracetamol tablets in healthy volunteers,”European Journal of Clinical Pharmacology, 2000, 56(2), 141-143.
Schúrch, S. et al., “Particles at the airway interfaces of the lung,”Colloids and surfaces B: Biointerfaces, 1999, 15, 339-353.
Sham, J.-H. et al., “Formulation and characterization of spray—dried powders containing nanoparticles for aerosol delivery to the lung,”International Journal of Pharmaceutics, 2004, 269, 457-467.
Sommerfeld, P. et al., “Sterilization of unloaded polybutylcyanoacrylate nanoparticles,”International Journal of Pharmaceutics, 1998, 164, 113-118.
Steckel, H. et al., “A novel spray—drying technique to produce low density particles for pulmonary delivery,”International Journal of Pharmaceutics, 2004, 278, 187-95.
Suarez, S. et al., “Airways delivery of rifampicin microparticles for the treatment of tuberculosis,”Journal of Antimicrobial Chemeotherapy, 2001, 48, 431-434.
Tsapis, N. et al., “Trojan particles: Large porous carrier of nanoparticles for drug delivery,”Proc. Natl. Acad. Sci., 2002, 99, 12001-12005.
Vanbever, R. et al., “Formulation and Physical Characterization of Large Porous Particles for Inhalation,”Pharmaceutical Research, 1999, 16(11), 1735-1742.
Voss, A. et al., “Degglomeration of dry powder pharmaceutical aerosols,”International Journal of Pharmaceutics, 2002, 248, 39-50.
Wang, Z. et al., “A Dry Powder Inhaler with Reduced Mouth-throat Deposition,”J. Aerosol Med., 2006, 19(2) 168-174.
Zahoor, A. et al., “Inhalable alginate nanoparticles as antitubecular drug carriers against experimental tuberculosis,”International Journal of Antimicrobial Agents, 2005, 26, 298-303.

Affiliated with

Also associated with

Rating

Effervescent powders for inhalation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Effervescent powders for inhalation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Effervescent powders for inhalation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2658422